Patents by Inventor Jung Yun Lee

Jung Yun Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240138255
    Abstract: Provided is a compound of Chemical Formula 1 or 2: wherein: R1 to R4 are each independently hydrogen or deuterium; n1 to n4 are an integer of 1 to 4; L1 and L2 are each independently a direct bond or a substituted or unsubstituted C6-60 arylene; and Ar1 and Ar2 are each independently a substituent of Chemical Formula 3: wherein X1 to X5 are each independently N or C(R5), wherein at least two of X1 to X5 are N; and each R5 is independently hydrogen, deuterium, a substituted or unsubstituted C1-20 alkyl, a substituted or unsubstituted C6-60 aryl, or a substituted or unsubstituted C2-60 heteroaryl containing at least one of N, O and S, or two adjacent R5s combine to form a benzene ring; and an organic light emitting device including the same. The device exhibits significantly superior efficiency and lifespan.
    Type: Application
    Filed: February 28, 2022
    Publication date: April 25, 2024
    Inventors: Dong Uk HEO, Heekyung YUN, Miyeon HAN, Jae Tak LEE, Jung Min YOON, Hoyoon PARK, Sung Kil HONG
  • Patent number: 11958844
    Abstract: The present invention relates to novel compounds having a histone deacetylase 6 (HDAC6) inhibitory activity, optical isomers thereof or pharmaceutically acceptable salts thereof, a pharmaceutical use thereof, and a method for preparing the same. According to the present invention, the novel compounds, optical isomers thereof or pharmaceutically acceptable salts thereof have the histone deacetylase 6 (HDAC6) inhibitory activity, and are effective in preventing or treating HDAC6-related diseases, comprising infectious diseases; neoplasm; internal secretion; nutritional and metabolic diseases; mental and behavioral disorders; neurological diseases; eye and ocular adnexal diseases; circulatory diseases; respiratory diseases; digestive diseases; skin and subcutaneous tissue diseases; musculoskeletal system and connective tissue diseases; and teratosis or deformities, and chromosomal aberration.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: April 16, 2024
    Assignee: Chong Kun Dang Pharmaceutical Corp.
    Inventors: Chang Sik Lee, Jung Taek Oh, Hokeun Yun, Hyeseung Song, Hyunjin Michael Kim
  • Publication number: 20240120495
    Abstract: A lithium free battery comprising a positive electrode, a negative electrode, a separator, and a non-aqueous lithium electrolyte, wherein the negative electrode includes a metal substrate including at least one metal selected from the group consisting of Mg, Ca, Al, Si, Ge, Sn, Pb, As, Sb, Bi, Ag, Zn, Cd, P and Hg; a lithium-metal alloy layer formed on the metal substrate; and a lithium plating layer formed on the lithium-metal alloy layer, and a method for preparing the same.
    Type: Application
    Filed: May 7, 2021
    Publication date: April 11, 2024
    Inventors: Hyunwoong Yun, Jung Pil Lee, Hoejin Hah
  • Publication number: 20240117389
    Abstract: The present disclosure is to provide a method capable of producing an organic acid in high yield from an acetic acid strain using synthesis gas as a substrate. According to the present disclosure, the productivity of metabolites with C2 to C6 carbon atoms derived from synthesis gas and the selectivity of hexanoic acid production among metabolites can be improved through a first fermentation step of simultaneously providing a substrate comprising synthesis gas and sugar; and a second fermentation step of semi-mixotrophic fermentation of providing only the substrate comprising the synthesis gas. Therefore, the disclosure can contribute to sustainable chemical production using synthesis gas.
    Type: Application
    Filed: September 19, 2023
    Publication date: April 11, 2024
    Inventors: Youngsoon UM, Deurim YUN, Sun Mi LEE, Gyeongtaek GONG, Ja Kyong KO, Jung Ho AHN
  • Patent number: 11951130
    Abstract: The present invention relates to an antigen-binding molecule comprising a heavy chain variable region comprising a heavy-chain complementarity-determining region 1 (HCDR1) comprising an amino acid sequence represented by Sequence No. 1, an HCDR2 comprising an amino acid sequence represented by Sequence No. 2, and an HCDR3 comprising an amino acid sequence represented by Sequence No. 3; a light-chain variable region comprising a light-chain complementarity-determining region 1 (LCDR1) comprising an amino acid sequence represented by Sequence No. 4, an LCDR2 comprising an amino acid sequence represented by Sequence No. 5, and an LCDR3 comprising an amino acid sequence represented by Sequence No. 6; wherein the antigen-binding molecule is a T cell receptor (TCR); and to a cell line expressing the same.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: April 9, 2024
    Assignee: Eutilex Co., Ltd.
    Inventors: Byoung S. Kwon, Young Ho Kim, Kwang Hee Kim, Ji Won Chung, Young Gyoon Chang, Bo Rim Yi, Jung Yun Lee, Seung Hyun Lee, Sun Woo Im, Jin Kyung Choi, Hyun Tae Son, Eun Hye Yoo
  • Publication number: 20240105961
    Abstract: A negative electrode current collector for a lithium free battery, the negative electrode current collector including a metal current collecting substrate, a conductive layer that is formed on at least one surface of the metal current collecting substrate and includes a conductive material, and an auxiliary layer that is formed on the conductive layer and increases a electrodeposition density of lithium.
    Type: Application
    Filed: May 7, 2021
    Publication date: March 28, 2024
    Inventors: Hyunwoong Yun, Jung Pil Lee, Hoejin Hah
  • Patent number: 11943994
    Abstract: A display device and a method of manufacturing the same are provided. The display device, comprises a first base substrate, a first barrier layer disposed on the first base substrate, a second base substrate disposed on the first barrier layer, at least one transistor disposed on the second base substrate, and an organic light emitting diode disposed on the at least one transistor, wherein the first barrier layer includes a silicon oxide, and has an adhesion force of 200 gf/inch or more to the second base substrate.
    Type: Grant
    Filed: August 17, 2021
    Date of Patent: March 26, 2024
    Assignee: Samsung Display Co., Ltd.
    Inventors: Chul Min Bae, Eun Jin Kwak, Jin Suk Lee, Jung Yun Jo, Ji Hye Han, Young In Hwang
  • Publication number: 20240096958
    Abstract: An embodiment is a semiconductor structure. The semiconductor structure includes a fin on a substrate. A gate structure is over the fin. A source/drain is in the fin proximate the gate structure. The source/drain includes a bottom layer, a supportive layer over the bottom layer, and a top layer over the supportive layer. The supportive layer has a different property than the bottom layer and the top layer, such as a different material, a different natural lattice constant, a different dopant concentration, and/or a different alloy percent content.
    Type: Application
    Filed: November 28, 2023
    Publication date: March 21, 2024
    Inventors: Jung-Chi Tai, Chii-Horng Li, Pei-Ren Jeng, Yen-Ru Lee, Yan-Ting Lin, Chih-Yun Chin
  • Publication number: 20220031742
    Abstract: The present invention relates to an antigen-binding molecule comprising a heavy chain variable region comprising a heavy-chain complementarity-determining region 1 (HCDR1) comprising an amino acid sequence represented by Sequence No. 1, an HCDR2 comprising an amino acid sequence represented by Sequence No. 2, and an HCDR3 comprising an amino acid sequence represented by Sequence No. 3; a light-chain variable region comprising a light-chain complementarity-determining region 1 (LCDR1) comprising an amino acid sequence represented by Sequence No. 4, an LCDR2 comprising an amino acid sequence represented by Sequence No. 5, and an LCDR3 comprising an amino acid sequence represented by Sequence No. 6; wherein the antigen-binding molecule is a T cell receptor (TCR); and to a cell line expressing the same.
    Type: Application
    Filed: March 1, 2021
    Publication date: February 3, 2022
    Inventors: Byoung S. Kwon, Young Ho Kim, Kwang Hee Kim, Ji Won Chung, Young Gyoon Chang, Bo Rim Yi, Jung Yun Lee, Seung Hyun Lee, Sun Woo Im, Jin Kyung Choi, Hyun Tae Son, Eun Hye Yoo
  • Patent number: 11013765
    Abstract: The present invention relates to an antigen-binding molecule comprising a heavy chain variable region comprising a heavy-chain complementarity-determining region 1 (HCDR1) comprising an amino acid sequence represented by Sequence No. 1, an HCDR2 comprising an amino acid sequence represented by Sequence No. 2, and an HCDR3 comprising an amino acid sequence represented by Sequence No. 3; a light-chain variable region comprising a light-chain complementarity-determining region 1 (LCDR1) comprising an amino acid sequence represented by Sequence No. 4, an LCDR2 comprising an amino acid sequence represented by Sequence No. 5, and an LCDR3 comprising an amino acid sequence represented by Sequence No. 6; wherein the antigen-binding molecule is a T cell receptor (TCR); and to a cell line expressing the same.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: May 25, 2021
    Inventors: Byoung S. Kwon, Young Ho Kim, Kwang Hee Kim, Ji Won Chung, Young Gyoon Chang, Bo Rim Yi, Jung Yun Lee, Seung Hyun Lee, Sun Woo Im, Jin Kyung Choi, Hyun Tae Son, Eun Hye Yoo
  • Publication number: 20200237821
    Abstract: The present invention relates to an antigen-binding molecule comprising a heavy chain variable region comprising a heavy-chain complementarity-determining region 1 (HCDR1) comprising an amino acid sequence represented by Sequence No. 1, an HCDR2 comprising an amino acid sequence represented by Sequence No. 2, and an HCDR3 comprising an amino acid sequence represented by Sequence No. 3; a light-chain variable region comprising a light-chain complementarity-determining region 1 (LCDR1) comprising an amino acid sequence represented by Sequence No. 4, an LCDR2 comprising an amino acid sequence represented by Sequence No. 5, and an LCDR3 comprising an amino acid sequence represented by Sequence No. 6; wherein the antigen-binding molecule is a T cell receptor (TCR); and to a cell line expressing the same.
    Type: Application
    Filed: December 16, 2019
    Publication date: July 30, 2020
    Inventors: Byoung S. Kwon, Young Ho Kim, Kwang Hee Kim, Ji Won Chung, Young Gyoon Chang, Bo Rim Yi, Jung Yun Lee, Seung Hyun Lee, Sun Woo Im, Jin Kyung Choi, Hyun Tae Son, Eun Hye Yoo
  • Patent number: 9180364
    Abstract: A primary game controller for use by a mobility impaired person by interfacing with a peripheral controller that allows the user to input precise movements needed for certain game functions. The peripheral controller may be operated by a part of a user's body in which the user has sufficient motor control, while the primary game controller may provide control inputs that require lesser motor control to operate. A control unit on the game controller may transmit control signals from the game controller and the peripheral controller, or may exclusively use the peripheral controller as the input for certain game functions. The game controller may be sized to be able to rest on a user's lap and to provide bigger control inputs.
    Type: Grant
    Filed: April 12, 2012
    Date of Patent: November 10, 2015
    Assignee: LP ACCESSIBLE TECHNOLOGIES, LLC
    Inventors: Luis Peña, David Aitchison, Barry Robb, Jung-Yun Lee, Hermann A. Hofer, Kaylin Winkelmann
  • Publication number: 20130012322
    Abstract: A primary game controller for use by a mobility impaired person by interfacing with a peripheral controller that allows the user to input precise movements needed for certain game functions. The peripheral controller may be operated by a part of a user's body in which the user has sufficient motor control, while the primary game controller may provide control inputs that require lesser motor control to operate. A control unit on the game controller may transmit control signals from the game controller and the peripheral controller, or may exclusively use the peripheral controller as the input for certain game functions. The game controller may be sized to be able to rest on a user's lap and to provide bigger control inputs.
    Type: Application
    Filed: April 12, 2012
    Publication date: January 10, 2013
    Inventors: Luis PENA, David Aitchison, Barry Robb, Jung-Yun Lee, Hermann A. Hofer, Kaylin Winkelmann
  • Patent number: 7720483
    Abstract: A sub-channel assignment apparatus and method of minimizing interference caused by sub-channel frequency overlaps when assigning sub-channels for sectors of a base station in an OFDMA system of a FDMA type. The apparatus includes: a plurality of sector channel management parts that assign at least one channel having assignable channel indexes in response to requests from users in a sector managed by the sector channel management part, and report sector load information regarding the total number of the requests from the users in the sector; and a channel assignment scheduler for using the sector load information reported from each channel management part to calculate the number of assignable channels per class for each of the sectors, and determines the assignable channel indexes per class for each of the sectors according to the number of assignable channels, and forwards the assignable channel indexes to each of the sector channel management parts.
    Type: Grant
    Filed: October 11, 2006
    Date of Patent: May 18, 2010
    Assignee: LG-Nortel Co., Ltd.
    Inventors: Dong Hun Kim, Jung Yun Lee, Keun Young Kim
  • Patent number: 7035662
    Abstract: A method and apparatus can manage power in a mobile communication system according to a call setup in a user equipment. The method can include setting a radio link in response to a setup command, receiving a radio access bearer allocation request command to reset a down link power range, and performing a radio link reconfiguration with the base station; transmitting a down link power measurement request command to adjust the down link power range in response to a down link power measurement result; reconfiguring a radio link in response to the adjusted down link power range. The transmitting and reconfiguring can be repeatedly performed for user equipment. Accordingly, an excessive down link power allocation to a specific subscriber and an abrupt variation of a total down link power can be reduced, and a number of subscribers, who respective cells can accommodate by a call starting control, can be increased.
    Type: Grant
    Filed: December 27, 2002
    Date of Patent: April 25, 2006
    Assignee: LG Electronics Inc.
    Inventor: Jung Yun Lee
  • Publication number: 20030125069
    Abstract: A method and apparatus can manage power in a mobile communication system according to a call setup in a user equipment. The method can include setting a radio link in response to a setup command, receiving a radio access bearer allocation request command to reset a down link power range, and performing a radio link reconfiguration with the base station; transmitting a down link power measurement request command to adjust the down link power range in response to a down link power measurement result; reconfiguring a radio link in response to the adjusted down link power range. The transmitting and reconfiguring can be repeatedly performed for user equipment. Accordingly, an excessive down link power allocation to a specific subscriber and an abrupt variation of a total down link power can be reduced, and a number of subscribers, who respective cells can accommodate by a call starting control, can be increased.
    Type: Application
    Filed: December 27, 2002
    Publication date: July 3, 2003
    Applicant: LG Electronics Inc.
    Inventor: Jung Yun Lee